Evidence map›Paper›PMID 34442034›Full record

ArticleJournal of clinical medicine2021

Prevalence and Prognostic Value of

Isabel Arnau-Barrés, Ana Pascual-Dapena, Inmaculada López-Montesinos, Silvia Gómez-Zorrilla, Luisa Sorlí, Marta Herrero, Xavier Nogués, Mila Montero, Olga Vázquez, Natalia García-Giralt and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Isabel Arnau-BarrésDepartment of Geriatrics, Hospital del Mar, 08003 Barcelona, Spain.
Ana Pascual-DapenaDepartament de Medicina, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Inmaculada López-MontesinosDepartment of Infectious Diseases, Institute Hospital del Mar of Medical Research, Hospital del Mar, IMIM, 08003 Barcelona, Spain.
Silvia Gómez-ZorrillaDepartment of Infectious Diseases, Institute Hospital del Mar of Medical Research, Hospital del Mar, IMIM, 08003 Barcelona, Spain.ORCID 0000-0002-5987-068X
Luisa SorlíDepartment of Infectious Diseases, Institute Hospital del Mar of Medical Research, Hospital del Mar, IMIM, 08003 Barcelona, Spain.
Marta HerreroDepartment of Geriatrics, Hospital del Mar, 08003 Barcelona, Spain.
Xavier NoguésDepartment of Internal MedicineInstitute Hospital del Mar of Medical Research, Hospital del Mar, IMIM, 08003 Barcelona, Spain.ORCID 0000-0002-5537-1859
Mila MonteroDepartment of Infectious Diseases, Institute Hospital del Mar of Medical Research, Hospital del Mar, IMIM, 08003 Barcelona, Spain.
Olga VázquezDepartment of Geriatrics, Hospital del Mar, 08003 Barcelona, Spain.
Natalia García-GiraltDepartment of Internal MedicineInstitute Hospital del Mar of Medical Research, Hospital del Mar, IMIM, 08003 Barcelona, Spain.ORCID 0000-0001-6507-0147
Ramón MirallesDepartament de Medicina, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Robert Güerri-FernándezDepartament de Medicina, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
Hospital Del Mar · ESUniversitat Autònoma de Barcelona · ES

Funding

Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable CB16/10/00245Instituto de Salud Carlos III PI19/00019
6 · The paper itself

Abstract

Myocardial involvement during SARS-CoV-2 infection has been reported in many prior publications. We aim to study the prevalence and the clinical implications of acute myocardial injury (MIN) during SARS-CoV-2 infection, particularly in older patients. The method includes a longitudinal observational study with all consecutive adult patients admitted to a COVID-19 unit between March-April 2020. Those aged ≥65 were considered as older adult group. MIN was defined as at least 1 high-sensitive troponin (hs-TnT) concentration above the 99th percentile upper reference limit with different sex-cutoff. Results. Among the 634 patients admitted during the period of observation, 365 (58%) had evidence of MIN, and, of them, 224 (61%) were older adults. Among older adults, MIN was associated with longer time to recovery compared to those without MIN (13 days (IQR 6-21) versus 9 days (IQR 5-17);

Indexed as

myocardial injuryolder adultsprognosisSARS-CoV-2

Identifiers

PMID34442034
PMCPMC8397085
OpenAlexW3118461432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.